As the known oncomir, miR-17∼92, is regulated by BCR-ABL fusion in chronic myeloid leukaemia, we investigated its role in BCR-ABL translocated ALL. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.